Our HIV research at the International AIDS Society 2023 Conference on HIV Science
19 Jul 2023
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutions will showcase their latest work on HIV trials at the 12th International AIDS Society (IAS) Conference on HIV Science. This year’s conference takes place from Sunday 23rd to Wednesday 26th July in Brisbane, Australia, and virtually.
Our HIV trials will feature in talks and posters at the main IAS conference, as well as the pre-conference International Workshop on HIV & Pediatrics 2023, running from Friday 21st to Saturday 22nd July in Brisbane and virtually.
The IAS is a global community of scientists, policymakers and activists. Its biennial Conference on HIV Science is a highly influential meeting on HIV research and its applications. The meeting covers the latest developments in HIV and AIDS clinical trials, as well as basic and operational HIV research.
Details of the MRC CTU at UCL presentations taking place at the conference and pre-conference workshops are shown below.
International Workshop on HIV & Pediatrics 2023
| Date and time (AEST) | Session | Title | Presenter | |
| Friday 21st July, 11:20 AM | Session 2 - Pediatric care and treatment: Advanced HIV Disease (AHD) in children and adolescents |
Increasing second-line ART options for children with HIV in Africa: week-96 efficacy and safety results of the CHAPAS-4 randomised trial |
Mutsa Bwakura-Dangarembizi | |
| Friday 21st July - Saturday 22nd July | Poster sessions |
Impact of COVID-19 pandemic on HIV viral load testing in paediatric HIV clinics in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) |
Siobhan Crichton | |
| Friday 21st July - Saturday 22nd July | Poster sessions |
Uptake and outcomes of tenofovir alafenamide fumarate (TAF)–based therapy in children and young people living with HIV (CLWHIV) in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) |
Siobhan Crichton | |
| Friday 21st July - Saturday 22nd July | Poster sessions |
Virological suppression and weight gain in children in Europe on dolutegravir compared to protease inhibitors: a propensity score analysis |
Siobhan Crichton | |
| Friday 21st July - Saturday 22nd July | Poster sessions |
Integrase inhibitor use in children living with HIV in Europe & Thailand over the last decade (2010-2020): uptake and virological response |
Jeannie Collins | |
| Friday 21st July - Saturday 22nd July | Poster sessions |
Early virological response to dolutegravir in children and adolescents living with HIV in the Ugandan UP ART cohort study |
Eleanor Namusoke-Magongo | |
IAS 2023 Conference on HIV Science
| Date and time (AEST) | Session | Title | Presenter |
| Monday 24th July, 1:58 PM | Plenary session - Long-acting technologies: A game changer? (PL01) | Long-acting treatment in adolescents | Cissy Kityo Mutuluuza |
| Tuesday 25th July. 10:41 AM | Track B - Clinical Science (OALBB05) |
Increasing second-line antiretroviral therapy options for children with HIV in Africa: week-96 efficacy and safety results of the CHAPAS-4 randomised trial |
Victor Musiime |
| Sunday 23rd July - Wednesday 26th July | Poster session (EPB0277) | Impact of COVID-19 pandemic on HIV viral load testing in paediatric HIV clinics in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) | Siobhan Crichton |
| Sunday 23rd July - Wednesday 26th July | Poster session (EPB0247) | Uptake and outcomes of tenofovir alafenamide fumarate (TAF)–based therapy in children and young people living with HIV (CLWHIV) in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) | Siobhan Crichton |
| Sunday 23rd July - Wednesday 26th July | Poster session (EPB0253) | Integrase inhibitor use in children living with HIV in Europe & Thailand over the last decade (2010-2020): uptake and virological response | Jeannie Collins |